Neuromuscular Disorders 2012
DOI: 10.5772/28864
|View full text |Cite
|
Sign up to set email alerts
|

Facioscapulohumeral Muscular Dystrophy: From Clinical Data to Molecular Genetics and Return

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 152 publications
1
3
0
Order By: Relevance
“…Of them, one subject (FSHD18_I:2) carried a short 4qB allele, which is not permissive for FSHD, whereas the other individuals displayed a short 4qA allele <10 RU, representing thereby non‐penetrant gene carriers. Interestingly, most of them (18/20) were females, in line with previous studies reporting a higher proportion of women among the asymptomatic/unaffected carriers 8–19 . The non‐penetrant gene carriers showed an average age of 60 years, except for 3 younger (<35 years of age) subjects (FSHD51_II:2, FSHD68_II:1, and FSHD100_II:2) that should be monitored to rule out the manifestation of FSHD later in life.…”
Section: Resultssupporting
confidence: 84%
See 3 more Smart Citations
“…Of them, one subject (FSHD18_I:2) carried a short 4qB allele, which is not permissive for FSHD, whereas the other individuals displayed a short 4qA allele <10 RU, representing thereby non‐penetrant gene carriers. Interestingly, most of them (18/20) were females, in line with previous studies reporting a higher proportion of women among the asymptomatic/unaffected carriers 8–19 . The non‐penetrant gene carriers showed an average age of 60 years, except for 3 younger (<35 years of age) subjects (FSHD51_II:2, FSHD68_II:1, and FSHD100_II:2) that should be monitored to rule out the manifestation of FSHD later in life.…”
Section: Resultssupporting
confidence: 84%
“…Interestingly, most of them (18/20) were females, in line with previous studies reporting a higher proportion of women among the asymptomatic/unaffected carriers. [8][9][10][11][12][13][14][15][16][17][18][19] The nonpenetrant gene carriers showed an average age of 60 years, except for 3 younger (<35 years of age) subjects (FSHD51_II:2, FSHD68_II:1, and FSHD100_II:2) that should be monitored to rule out the manifestation of FSHD later in life.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations